摘要 |
The invention provides a compound of Formula I Formula I wherein R<SUP>1 </SUP>is aryl or heteroaryl each of which is optionally substituted with one or more of the following R<SUP>3</SUP>, -OR<SUP>3</SUP>, -OCOR<SUP>3</SUP>, -COOR<SUP>3</SUP>, -COR<SUP>3</SUP>, -CONR<SUP>3</SUP>R<SUP>4</SUP>, -NHCOR<SUP>3</SUP>, -NR<SUP>3</SUP>R<SUP>4</SUP>, -NHSO<SUB>2</SUB>R<SUP>3</SUP>, -S<SUB>2</SUB>R<SUP>3</SUP>, -SO<SUB>2</SUB>NR<SUP>3</SUP>R<SUP>4</SUP>, -SR<SUP>3</SUP>, CN, halogeno or NO<SUB>2</SUB>; R<SUP>2 </SUP>is NO<SUB>2</SUB>, NH<SUB>2</SUB>, -NR<SUP>5</SUP>R<SUP>6 </SUP>or -NR<SUP>6</SUP>R<SUP>7</SUP>; as a free base or a pharmaceutically acceptable salt, solvate or solvate of salt thereof, a process for their preparation, pharmaceutical formulations containing said compounds and to the use of said compounds in therapy.
|